AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies
Authors
Keywords
-
Journal
BIODRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-25
DOI
10.1007/s40259-023-00629-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
- (2023) Sunil S. Patel et al. EYE
- Novel therapies for diabetic retinopathy
- (2022) Magdalena Kupis et al. Central European Journal of Immunology
- Review of gene therapies for age-related macular degeneration
- (2022) Arshad M. Khanani et al. EYE
- Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective
- (2022) Katharine L. Bunch et al. Frontiers in Physiology
- A hypoxia-regulated retinal pigment epithelium-specific gene therapy vector reduces choroidal neovascularization in a mouse model
- (2022) Yun Yuan et al. CURRENT GENE THERAPY
- Gene Delivery of a Caspase Activation and Recruitment Domain Improves Retinal Pigment Epithelial Function and Modulates Inflammation in a Mouse Model with Features of Dry Age-Related Macular Degeneration
- (2022) Mayur Choudhary et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Delivery of nVEGFi using AAV8 for the treatment of neovascular age-related macular degeneration
- (2022) Kaiqin She et al. Molecular Therapy-Methods & Clinical Development
- Viral Vectors for the in Vivo Delivery of CRISPR Components: Advances and Challenges
- (2022) Misganaw Asmamaw Mengstie Frontiers in Bioengineering and Biotechnology
- Experiment-Based Interventions to Diabetic Retinopathy: Present and Advances
- (2022) Siwei Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Correlation between genetic and environmental risk factors for age-related macular degeneration in Brazilian patients
- (2022) Priscila H. H. Rim et al. PLoS One
- mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
- (2022) Steven Hyun Seung Lee et al. PLoS One
- Fantastic AAV Gene Therapy Vectors and How to Find Them—Random Diversification, Rational Design and Machine Learning
- (2022) Jonas Becker et al. Pathogens
- Precision genome editing in the eye
- (2022) Susie Suh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of complement C3 inhibitor pegcetacoplan with reduced photoreceptor degeneration beyond areas of geographic atrophy
- (2022) Maximilian Pfau et al. Scientific Reports
- Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations
- (2022) Ahmed Salman et al. Pharmaceutics
- Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells
- (2021) Anna K. Dreismann et al. GENE THERAPY
- Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates
- (2021) Szilárd Kiss et al. Translational Vision Science & Technology
- Humoral immune responses to AAV gene therapy in the ocular compartment
- (2021) Michael Whitehead et al. BIOLOGICAL REVIEWS
- Emerging therapies and their delivery for treating age‐related macular degeneration
- (2021) Chloe N. Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
- Comprehensive Preclinical Assessment of ADVM-022, an Intravitreal Anti-VEGF Gene Therapy for the Treatment of Neovascular AMD and Diabetic Macular Edema
- (2021) Claire M. Gelfman et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis
- (2021) Zhen Ling Teo et al. OPHTHALMOLOGY
- Age-related macular degeneration
- (2021) Monika Fleckenstein et al. Nature Reviews Disease Primers
- Diabetic eye: associated diseases, drugs in clinic, and role of self-assembled carriers in topical treatment
- (2021) Axel Kattar et al. Expert Opinion on Drug Delivery
- Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
- (2021) Shuqi Qin et al. Journal of Immunology Research
- Erythropoietin Gene Therapy Delays Retinal Degeneration Resulting from Oxidative Stress in the Retinal Pigment Epithelium
- (2021) Manas R. Biswal et al. Antioxidants
- MicroRNA and diabetic retinopathy—biomarkers and novel therapeutics
- (2021) Zeljka Smit-McBride et al. Annals of Translational Medicine
- Silencing Nogo-B improves the integrity of blood-retinal barrier in diabetic retinopathy via regulating Src, PI3K/Akt and ERK pathways
- (2021) Qian Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel Treatments for Diabetic Macular Edema and Proliferative Diabetic Retinopathy
- (2021) Nhon T. Le et al. Current Diabetes Reports
- Early and late stage gene therapy interventions for inherited retinal degenerations
- (2021) Catherine Botto et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Gene-Based Therapeutics for Acquired Retinal Disease: Opportunities and Progress
- (2021) Tien-En Tan et al. Frontiers in Genetics
- Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration
- (2020) Valentina Cipriani et al. Nature Communications
- Updates on Gene Therapy for Diabetic Retinopathy
- (2020) Jiang-Hui Wang et al. Current Diabetes Reports
- Epigenetics and Mitochondrial Stability in the Metabolic Memory Phenomenon Associated with Continued Progression of Diabetic Retinopathy
- (2020) Renu A. Kowluru et al. Scientific Reports
- Neutralisation of adeno-associated virus transduction by human vitreous humour
- (2020) Sławomir Andrzejewski et al. GENE THERAPY
- Gene Therapy Intervention in Neovascular Eye Disease: A Recent Update
- (2020) Fan-Li Lin et al. MOLECULAR THERAPY
- Synthetically Engineered Adeno-Associated Virus for Efficient, Safe, and Versatile Gene Therapy Applications
- (2020) Margaret L. Lugin et al. ACS Nano
- Retinal Tropism and Transduction of Adeno-Associated Virus Varies by Serotype and Route of Delivery (Intravitreal, Subretinal, or Suprachoroidal) in Rats
- (2020) Ian C. Han et al. HUMAN GENE THERAPY
- Immune responses to retinal gene therapy using adeno-associated viral vectors – Implications for treatment success and safety
- (2020) Kirsten Bucher et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025
- (2020) Xiling Lin et al. Scientific Reports
- Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD
- (2020) Szilárd Kiss et al. Molecular Therapy-Methods & Clinical Development
- Overexpression of d-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats
- (2020) Haiyan Jiang et al. DIABETOLOGIA
- Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
- (2020) Jaimie D Steinmetz et al. Lancet Global Health
- Viral Delivery Systems for CRISPR
- (2019) Christine Xu et al. Viruses-Basel
- Adeno-associated virus vector as a platform for gene therapy delivery
- (2019) Dan Wang et al. NATURE REVIEWS DRUG DISCOVERY
- Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives
- (2019) Thierry Bordet et al. DRUG DISCOVERY TODAY
- Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
- (2019) Anne Louise Askou et al. Molecular Therapy-Nucleic Acids
- Angiopoietins in Diabetic Retinopathy: Current Understanding and Therapeutic Potential
- (2019) Michael Whitehead et al. Journal of Diabetes Research
- Expression of a CARD Slows the Retinal Degeneration of a Geographic Atrophy Mouse Model
- (2019) Brianna M. Young et al. Molecular Therapy-Methods & Clinical Development
- Effects of Stuffer DNA on the Suppression of Choroidal Neovascularization by a rAAV Expressing a mTOR-Inhibiting shRNA
- (2019) Steven Hyun Seung Lee et al. Molecular Therapy-Methods & Clinical Development
- AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression
- (2019) Kun Ding et al. JOURNAL OF CLINICAL INVESTIGATION
- Optimal Inhibition of Choroidal Neovascularization by scAAV2 with VMD2 Promoter-driven Active Rap1a in the RPE
- (2019) Haibo Wang et al. Scientific Reports
- Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy
- (2018) Patricia S. Graham et al. BMC Medical Genetics
- AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration
- (2018) Yuanyuan Liu et al. MOLECULAR THERAPY
- Mechanisms of macular edema: Beyond the surface
- (2018) Alejandra Daruich et al. PROGRESS IN RETINAL AND EYE RESEARCH
- CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
- (2018) Taeyoung Koo et al. Nature Communications
- Transduction Patterns of Adeno-associated Viral Vectors in a Laser-Induced Choroidal Neovascularization Mouse Model
- (2018) Si Hyung Lee et al. Molecular Therapy-Methods & Clinical Development
- Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization
- (2018) Gloriane Schnabolk et al. Molecular Therapy-Methods & Clinical Development
- Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization
- (2018) Manas R. Biswal et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Gene therapy for visual loss: Opportunities and concerns
- (2018) Jia Hui Lee et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections
- (2018) P. ET. Lau et al. Journal of Ophthalmology
- Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
- (2018) Ruslan Grishanin et al. MOLECULAR THERAPY
- Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye
- (2018) Gerard A. Rodrigues et al. PHARMACEUTICAL RESEARCH
- AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization
- (2018) Chris P. Hughes et al. Molecular Therapy-Methods & Clinical Development
- Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
- (2017) Peter A. Campochiaro et al. HUMAN GENE THERAPY
- A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization
- (2017) Yiming Li et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial
- (2017) Jeffrey S Heier et al. LANCET
- Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
- (2017) Stephen Russell et al. LANCET
- Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
- (2017) Ken Y Chan et al. NATURE NEUROSCIENCE
- Gene therapy for diabetic retinopathy: Are we ready to make the leap from bench to bedside?
- (2017) Jiang-Hui Wang et al. PHARMACOLOGY & THERAPEUTICS
- Genome editing abrogates angiogenesis in vivo
- (2017) Xionggao Huang et al. Nature Communications
- Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization
- (2017) Tae Kwann Park et al. Molecular Therapy-Nucleic Acids
- Adeno-Associated Virus Overexpression of Angiotensin-Converting Enzyme-2 Reverses Diabetic Retinopathy in Type 1 Diabetes in Mice
- (2016) James M. Dominguez et al. AMERICAN JOURNAL OF PATHOLOGY
- Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review
- (2016) Daniel Shu Wei Ting et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Advances in Gene Therapy for Diseases of the Eye
- (2016) Lolita Petit et al. HUMAN GENE THERAPY
- AAV-mediated gene therapy in Dystrophin-Dp71 deficient mouse leads to blood-retinal barrier restoration and oedema reabsorption
- (2016) Ophélie Vacca et al. HUMAN MOLECULAR GENETICS
- Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review
- (2016) Patrick Kaszubski et al. OPHTHALMIC RESEARCH
- In vivo tissue-tropism of adeno-associated viral vectors
- (2016) Arun Srivastava Current Opinion in Virology
- Diabetic retinopathy
- (2016) Tien Y. Wong et al. Nature Reviews Disease Primers
- Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration
- (2016) Ian J. Constable et al. EBioMedicine
- Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy
- (2015) Judd M. Cahoon et al. DIABETES
- Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1
- (2015) Nundehui Díaz-Lezama et al. LABORATORY INVESTIGATION
- Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial
- (2015) Elizabeth P Rakoczy et al. LANCET
- A Hypoxia-Responsive Glial Cell-Specific Gene Therapy Vector for Targeting Retinal Neovascularization
- (2014) M. R. Biswal et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
- (2014) Wan Ling Wong et al. Lancet Global Health
- Clinical Classification of Age-related Macular Degeneration
- (2013) Frederick L. Ferris et al. OPHTHALMOLOGY
- Animal models of age related macular degeneration
- (2012) Mark E. Pennesi et al. MOLECULAR ASPECTS OF MEDICINE
- Preclinical safety evaluation of subretinal AAV2.sFlt-1 in non-human primates
- (2011) C-M Lai et al. GENE THERAPY
- ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy
- (2011) Amrisha Verma et al. MOLECULAR THERAPY
- A Non Membrane-Targeted Human Soluble CD59 Attenuates Choroidal Neovascularization in a Model of Age Related Macular Degeneration
- (2011) Siobhan M. Cashman et al. PLoS One
- Dosage Thresholds for AAV2 and AAV8 Photoreceptor Gene Therapy in Monkey
- (2011) L. H. Vandenberghe et al. Science Translational Medicine
- Preclinical Safety Evaluation of AAV2-sFLT01— A Gene Therapy for Age-related Macular Degeneration
- (2010) Timothy K MacLachlan et al. MOLECULAR THERAPY
- Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule
- (2010) Michael Lukason et al. MOLECULAR THERAPY
- Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the Vitreous
- (2009) Deniz Dalkara et al. MOLECULAR THERAPY
- A Novel Adeno-Associated Viral Variant for Efficient and Selective Intravitreal Transduction of Rat Müller Cells
- (2009) Ryan R. Klimczak et al. PLoS One
- Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization
- (2008) P Pechan et al. GENE THERAPY
- Treatment of Leber Congenital Amaurosis Due to RPE65 Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
- (2008) William W. Hauswirth et al. HUMAN GENE THERAPY
- Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
- (2008) Albert M. Maguire et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis
- (2008) James W.B. Bainbridge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
- (2008) L. Zhong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started